Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Free Cash Flow: 2024-2025

Historic Free Cash Flow for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$83.2 million.

  • Kura Oncology's Free Cash Flow fell 91.51% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year change of. This contributed to the annual value of $133.8 million for FY2024, which is 207.08% up from last year.
  • Kura Oncology's Free Cash Flow amounted to -$83.2 million in Q3 2025, which was down 175.16% from -$30.2 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Free Cash Flow peaked at $268.8 million during Q4 2024, and registered a low of -$83.2 million during Q3 2025.
  • In the last 2 years, Kura Oncology's Free Cash Flow had a median value of -$43.4 million in 2024 and averaged -$7.4 million.
  • Data for Kura Oncology's Free Cash Flow shows a peak YoY increase of 28.94% (in 2025) and a maximum YoY decrease of 91.51% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Free Cash Flow (Quarterly) stood at $268.8 million in 2024, then slumped by 91.51% to -$83.2 million in 2025.
  • Its last three reported values are -$83.2 million in Q3 2025, -$30.2 million for Q2 2025, and -$72.2 million during Q1 2025.